Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Winquist

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Cancers of the Head & Neck|December 18, 2019
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survivalNeil Mundi, Stephenie D Prokopec, Farhad Ghasemi, et al.
Radiation Oncology (London, England)|August 16, 2020
Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trialPencilla Lang, Jessika Contreras, Noah Kalman, et al.
JAMA Oncology|December 9, 2016
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical TrialLillian L Siu, John N Waldron, Bingshu E Chen, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2021
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021Christina Canil, Anil Kapoor, Naveen S Basappa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II TrialNeil E Fleshner, Rashid K Sayyid, Aaron R Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, et al.
JAMA Oncology|September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical TrialSrikala S Sridhar, Normand Blais, Ben Tran, et al.
Oral Oncology|December 23, 2019
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancerMorgan Black, Farhad Ghasemi, Ren X Sun, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 12, 2019
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019Sebastien J Hotte, Anil Kapoor, Naveen S Basappa, et al.
The Journal of Molecular Diagnostics : JMD|February 7, 2026
Health care impact of comprehensive genomic profiling of solid tumors in patient management using POWER (Precision Oncology at Western University)Pratibha Bhai, Jacob P Turowec, Lee-Anne Pickard, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Cancers of the Head & Neck|December 18, 2019
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survivalNeil Mundi, Stephenie D Prokopec, Farhad Ghasemi, et al.
Radiation Oncology (London, England)|August 16, 2020
Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trialPencilla Lang, Jessika Contreras, Noah Kalman, et al.
JAMA Oncology|December 9, 2016
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical TrialLillian L Siu, John N Waldron, Bingshu E Chen, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2021
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021Christina Canil, Anil Kapoor, Naveen S Basappa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II TrialNeil E Fleshner, Rashid K Sayyid, Aaron R Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, et al.
JAMA Oncology|September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical TrialSrikala S Sridhar, Normand Blais, Ben Tran, et al.
Oral Oncology|December 23, 2019
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancerMorgan Black, Farhad Ghasemi, Ren X Sun, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 12, 2019
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019Sebastien J Hotte, Anil Kapoor, Naveen S Basappa, et al.
The Journal of Molecular Diagnostics : JMD|February 7, 2026
Health care impact of comprehensive genomic profiling of solid tumors in patient management using POWER (Precision Oncology at Western University)Pratibha Bhai, Jacob P Turowec, Lee-Anne Pickard, et al.
Pageof 24